Artificial intelligence has already transformed how scientific information is created, reviewed, and consumed. As AI tools become more deeply integrated into medical publishing and clinical practice, many of us are asking the same question: How can we take advantage of these technologies while maintaining trust, transparency, and scientific rigor? In this episode, we explore both the opportunities and the challenges that come with AI’s growing role in medical communications.
Joining us for this conversation is Raja-Elie Abdulnour, Editor-in-Chief of NEJM Clinician and Chief Clinical Innovation Officer at NEJM Group. Together, we discuss how AI is being used across editorial workflows, why disclosure and accountability matter, and what role editors play in safeguarding scientific honesty and rigor. To access the published paper, Can AI Say “I Don’t Know”?, referred to in this episode, please click here. To join ISMPP or participate in our Special Membership Offer, visit our website at https://www.ismpp.org/medcommsday.
Disclosure: NEJM Group has licensing agreements with several AI companies, including OpenEvidence, Abridged, and Perplexity.
